Further, the receiver operating characteristics (ROC) analysis indicated that CD90 expression could distinguish PDAC from normal, chronic pancreatitis and benign islet tumors with a specificity of 90% at a sensitivity of 84% (AUC = 0.937). This evidence concerns the gene THY1 and chronic pancreatitis.